You are here

Eli Lilly

Cancer Breakthrough Could Mean Big Gains for This Pharma Giant

Yahoo/Street Authority

Wed, 08/14/13 - 09:13 am

non-small cell lung cancer

The Next Big Opportunity in Antidepressant Drugs

Motley Fool

Tue, 08/13/13 - 11:08 am

antidepressants

major depressive disorder

Is This Biotech Stock Worth Buying After a Massive Post-IPO Surge?

Motley Fool

Tue, 08/13/13 - 11:06 am

Eli Lilly Lung Cancer Drug Raises Patient Survival in Trial

Bloomberg

Tue, 08/13/13 - 10:48 am

How Much To Develop A Drug? An Update

Seeking Alpha

Mon, 08/12/13 - 11:51 am

Feds Probe Antipsychotic Prescriptions For Children In Medicaid

Pharmalot

Mon, 08/12/13 - 09:13 am

Bristol-Myers Squibb

AstraZeneca’s

Novo Nordisk Getting Its Trial By Fire

Investopedia

Fri, 08/9/13 - 09:44 am

3 Companies Working to Make Migraines Milder

Motley Fool

Wed, 08/7/13 - 09:36 am

Arteaus Therapeutics

Alder Biopharmaceuticals

Bristol-Myers Squibb

Oramed Expands Diabetes Platform With Oral GLP-1 Agonist

Seeking Alpha

Tue, 08/6/13 - 10:00 am

Bristol-Myers Squibb

These Pharmaceutical Giants Are Teetering Dangerously Near The Patent Cliff

Motley Fool

Sat, 08/3/13 - 10:16 am

Bristol-Myers Squibb

J&J Fined in China as Eli Lilly, Sanofi Visited by Regulators

Bloomberg

Thu, 08/1/13 - 09:10 am

First Patient Enrolled in New Cardiovascular and Renal Outcomes Trial for TRADJENTA® (linagliptin) Tablets in Type 2 Diabetes

Yahoo/PR Newswire

Wed, 07/31/13 - 09:11 am

type 2 diabetes

Boehringer Ingelheim

BioPharma Catalyst Trade Pick Of The Week: Biodel

Seeking Alpha

Tue, 07/30/13 - 01:58 pm

What Does the Patent Cliff Mean for This Drugmaker?

Motley Fool

Fri, 07/26/13 - 09:05 am

Eli Lilly Tops Earnings Estimates, Raises FY Guidance Comment Now Follow Comments

Forbes

Wed, 07/24/13 - 09:31 am

The Diabetes Pipeline With a Clog

Motley Fool

Mon, 07/22/13 - 06:02 pm

Bristol-Myers Squibb

SGLT2 inhibitor

It's showtime for Eli Lilly

Motley Fool

Mon, 07/22/13 - 10:20 am

Bizarre Protection Against Alzheimer's: Cancer

Motley Fool

Sun, 07/21/13 - 11:39 am

5 Drugmakers With a Lot on the Line Next Week

Motley Fool

Sun, 07/21/13 - 11:37 am

Gilead Sciences

The U.S. Antidepressant Market: Old Fashioned Branding Might Save the Day

Motley Fool

Fri, 07/19/13 - 10:31 am

antidepressants

Pages